Tag: Metabolic-Associated Fatty Liver

MAFLD and GLP-1 Agonists: How Weight Loss Medications Help Fatty Liver Disease

MAFLD and GLP-1 Agonists: How Weight Loss Medications Help Fatty Liver Disease

Explore how GLP-1 agonists like semaglutide are transforming the treatment of Metabolic-Associated Fatty Liver Disease (MASLD). Learn about weight loss targets, drug comparisons, and real-world challenges.

Recent Posts

Understanding Controlled Substance Labels and Schedule Codes: A Patient's Guide
Apr, 26 2026
Understanding Controlled Substance Labels and Schedule Codes: A Patient's Guide

Learn how to read controlled substance labels and understand DEA schedule codes. Discover the difference between Schedule I-V drugs and how they affect your refills.

Steroid Myopathy: How to Recognize Weakness and Start Effective Physical Therapy
Dec, 23 2025
Steroid Myopathy: How to Recognize Weakness and Start Effective Physical Therapy

Steroid myopathy causes painless, progressive muscle weakness in people on long-term corticosteroids. Learn how to recognize early signs, avoid misdiagnosis, and start safe, effective physical therapy to regain strength.

Immunosuppressants: Transplant Medication Safety Essentials
Dec, 6 2025
Immunosuppressants: Transplant Medication Safety Essentials

Immunosuppressants prevent organ rejection after transplant but carry serious risks like infection, cancer, and kidney damage. Learn how to manage these drugs safely, avoid missed doses, and reduce long-term side effects.

Trimethoprim and Potassium Levels: Understanding the Hyperkalemia Risk
Dec, 8 2025
Trimethoprim and Potassium Levels: Understanding the Hyperkalemia Risk

Trimethoprim can cause dangerous spikes in potassium levels, especially in older adults or those on blood pressure meds. Learn who's at risk, how to prevent life-threatening hyperkalemia, and safer antibiotic alternatives.

How Governments Control Generic Drug Prices Without Direct Price Caps
Nov, 17 2025
How Governments Control Generic Drug Prices Without Direct Price Caps

Governments don't set prices for generic drugs - they let competition do it. Learn how FDA approvals, FTC enforcement, and market forces keep generic medications affordable without direct price controls.